Skip to main content

Table 2 Receiver operating characteristics analyses of LDH and dNLR

From: High score of LDH plus dNLR predicts poor survival in patients with HER2-positive advanced breast cancer treated with trastuzumab emtansine

Variables

AUC

Cut-off Value

Sensitivity

Specificity

P

LDH

0.793

244

0.621

0.812

0.003

dNLR

0.694

1.985

0.414

1.000

0.013

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us